These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 23835085)
1. Orthotopic transplantation of retinoblastoma cells into vitreous cavity of zebrafish for screening of anticancer drugs. Jo DH; Son D; Na Y; Jang M; Choi JH; Kim JH; Yu YS; Seok SH; Kim JH Mol Cancer; 2013 Jul; 12():71. PubMed ID: 23835085 [TBL] [Abstract][Full Text] [Related]
2. Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833 [TBL] [Abstract][Full Text] [Related]
3. L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma. Jo DH; Lee K; Kim JH; Jun HO; Kim Y; Cho YL; Yu YS; Min JK; Kim JH Oncotarget; 2017 Feb; 8(9):15441-15452. PubMed ID: 28061460 [TBL] [Abstract][Full Text] [Related]
4. Revisiting old drugs as novel agents for retinoblastoma: in vitro and in vivo antitumor activity of cardenolides. Antczak C; Kloepping C; Radu C; Genski T; Müller-Kuhrt L; Siems K; de Stanchina E; Abramson DH; Djaballah H Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3065-73. PubMed ID: 19151399 [TBL] [Abstract][Full Text] [Related]
5. An orthotopic glioblastoma animal model suitable for high-throughput screenings. Pudelko L; Edwards S; Balan M; Nyqvist D; Al-Saadi J; Dittmer J; Almlöf I; Helleday T; Bräutigam L Neuro Oncol; 2018 Oct; 20(11):1475-1484. PubMed ID: 29750281 [TBL] [Abstract][Full Text] [Related]
6. A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma. Mahida JP; Antczak C; Decarlo D; Champ KG; Francis JH; Marr B; Polans AS; Albert DM; Abramson DH; Djaballah H PLoS One; 2013; 8(3):e59156. PubMed ID: 23527118 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma. Daniels AB; Froehler MT; Pierce JM; Nunnally AH; Calcutt MW; Bridges TM; LaNeve DC; Williams PE; Boyd KL; Reyzer ML; Lindsley CW; Friedman DL; Richmond A Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):446-454. PubMed ID: 29368001 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo. Zhou Z; Jiang H; Xia J; Zhang J Int J Oncol; 2020 Sep; 57(3):697-706. PubMed ID: 32582992 [TBL] [Abstract][Full Text] [Related]
9. Antitumor Activity of Novel Signal Transducer and Activator of Transcription 3 Inhibitors on Retinoblastoma. Jo DH; Lee S; Bak E; Cho CS; Han YT; Kim K; Suh YG; Kim JH Mol Pharmacol; 2021 Jul; 100(1):63-72. PubMed ID: 34016717 [TBL] [Abstract][Full Text] [Related]
10. Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma. Nemeth KM; Federico S; Carcaboso AM; Shen Y; Schaiquevich P; Zhang J; Egorin M; Stewart C; Dyer MA Cancer; 2011 Jan; 117(2):421-34. PubMed ID: 20818652 [TBL] [Abstract][Full Text] [Related]
11. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds. Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261 [TBL] [Abstract][Full Text] [Related]
12. Eye-preservation treatment of retinoblastoma with vitreous seeding. Kaneko A; Suzuki S Jpn J Clin Oncol; 2003 Dec; 33(12):601-7. PubMed ID: 14769836 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of aflibercept in in vitro and in vivo models of retinoblastoma. Kim DY; Choi JA; Koh JY; Yoon YH J Exp Clin Cancer Res; 2016 Nov; 35(1):171. PubMed ID: 27814771 [TBL] [Abstract][Full Text] [Related]
14. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis. Wang Y; Xin D; Zhou L Med Sci Monit; 2020 Jun; 26():e920886. PubMed ID: 32541644 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma. Dalgard CL; Van Quill KR; O'Brien JM Clin Cancer Res; 2008 May; 14(10):3113-23. PubMed ID: 18483379 [TBL] [Abstract][Full Text] [Related]
16. Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier. Pascual-Pasto G; Olaciregui NG; Opezzo JAW; Castillo-Ecija H; Cuadrado-Vilanova M; Paco S; Rivero EM; Vila-Ubach M; Restrepo-Perdomo CA; Torrebadell M; Suñol M; Schaiquevich P; Mora J; Bramuglia GF; Chantada GL; Carcaboso AM J Control Release; 2017 Oct; 264():34-44. PubMed ID: 28830790 [TBL] [Abstract][Full Text] [Related]
17. Treating retinoblastoma in tissue culture and in a rat model with a novel isoquinoline derivative. Nassr M; Wang X; Mitra S; Freeman-Anderson NE; Patil R; Yates CR; Miller DD; Geisert EE Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3813-9. PubMed ID: 20570997 [TBL] [Abstract][Full Text] [Related]
18. Tridimensional Retinoblastoma Cultures as Vitreous Seeds Models for Live-Cell Imaging of Chemotherapy Penetration. Winter U; Aschero R; Fuentes F; Buontempo F; Zugbi S; Sgroi M; Sampor C; Abramson DH; Carcaboso AM; Schaiquevich P Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832308 [TBL] [Abstract][Full Text] [Related]
19. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report. Chao A; Kao LY; Liu L; Wang NK BMC Ophthalmol; 2016 Mar; 16():27. PubMed ID: 26975871 [TBL] [Abstract][Full Text] [Related]
20. Intraocular surgery with melphalan irrigation for vitreous hemorrhage in an only eye with retinoblastoma. Yarovoy AA; Ushakova TL; Gorshkov IM; Polyakov VG; Golubeva OV; Gorovtsova OV; Krivovyaz OS Eur J Ophthalmol; 2015 Dec; 26(1):e17-9. PubMed ID: 26428220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]